氨酸17调节胰腺癌的免疫地形
Lyanne A Delgado-Coka1, Michael Horowitz1, Mariana Torrente-Goncalves1
1Stony Brook University.
Research square
|March 11, 2024
概括
胰腺癌中的氨酸17 (K17) 表达与不太有利的免疫微环境有关,减少T细胞和巨细胞的透. 向K17可能会增强胰腺管道腺癌 (PDAC) 的免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 瘤免疫微环境显著影响胰腺管腺癌 (PDAC) 的进展和患者的结果.
- 氨酸17 (K17),是攻击性PDAC亚型的标记物,与其他癌症的免疫反应有关.
- 在PDAC的免疫格局中K17的作用仍然未被探索.
研究的目的:
- 调查PDAC微环境中的K17表达和免疫细胞组成之间的关联.
- 确定K17是否影响关键免疫细胞的空间分布和丰度.
- 探索K17作为改善PDAC免疫治疗策略的治疗标的潜力.
主要方法:
- 在235个PDAC样本上利用多重免疫组织化学 (mIHC).
- 采用自动图像分析来量化免疫细胞 (T细胞,巨细胞) 和瘤细胞.
- 与免疫透物的丰富性和空间分布相关的K17表达.
主要成果:
- 显著相关的K17表达与内CD8+T细胞的排除.
- 在表达K17的瘤中观察到周CD8+T细胞和CD16+和CD163+巨细胞数量的减少.
- 这些免疫变化独立于瘤阶段,等级,新辅助疗法和常见的遗传突变.
结论:
- K17表达极大地改变了PDAC免疫微环境,其特征是T细胞和巨细胞透率降低.
- 这些免疫变化是K17表达的内在因素,不受临床或分子因素的影响.
- 准K17可能是一种新的策略,可以重新激活免疫系统,并提高PDAC的免疫疗法疗效.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


